Response To Azacitidine Is Independent Of TP53 Mutations In Higher-Risk Myelodysplastic Syndromes (MDS) and Secondary Acute Myeloid Leukemia (sAML)

被引：1
|
作者：
Mueller-Thomas, Catharina
Rudelius, Martina
Rondak, Ina
Haferlach, Torsten
Schanz, Julie
Schmidt, Burkhard
Kremer, Markus
Germing, Ulrich
Platzbecker, Uwe
Peschel, Christian
Goetze, Katharina
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.2797.2797
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2797
引用
收藏
页数：2
相关论文
共 50 条
  • [41] NUMBER OF TP53 ABNORMALITIES AND THEIR CLINICAL RELEVANCE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES
    Montalban-Bravo, G.
    Benton, C.
    Kadia, T.
    Ravandi, F.
    Cortes, J.
    Daver, N.
    Takahashi, K.
    DiNardo, C.
    Jabbour, E.
    Borthakur, G.
    Pemmaraju, N.
    Konopleva, M.
    Alfonso, A.
    Pierce, S.
    Bueso-Ramos, C.
    Kornblau, S.
    Patel, K.
    Kantarjian, H.
    Andreeff, M.
    Garcia-Manero, G.
    HAEMATOLOGICA, 2017, 102 : 48 - 48
  • [42] Clinical impact of transformation to acute myeloid leukemia in patients with higher-risk myelodysplastic syndromes
    Kota, Vamsi
    Ogbonnaya, Augustina
    Farrelly, Eileen
    Schroader, Bridgette Kanz
    Raju, Aditya
    Kristo, Fjoralba
    Dalal, Mehul
    FUTURE ONCOLOGY, 2022, 18 (36) : 4017 - 4029
  • [43] Azacitidine Alone Or The Combination With Valproic Acid As a Bridge Therapy For Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes Before Transplantation
    Cabrera, Cristina Calderon
    Falantes, Jose F.
    Gomez, Marina
    Parody, Rocio
    Malaver, Francisco J. Marquez
    Martino, Marla L.
    Gonzalez, Jose
    Montero, Isabel
    Espigado, Ildefonso
    Perez-Simon, Jose Antonio
    BLOOD, 2013, 122 (21)
  • [44] A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes
    Mikkael A. Sekeres
    Michael Schuster
    Magalie Joris
    Jürgen Krauter
    Johan Maertens
    Dimitri Breems
    Emmanuel Gyan
    Tibor Kovacsovics
    Amit Verma
    Paresh Vyas
    Eunice S. Wang
    Keith Ching
    Thomas O’Brien
    Corrado Gallo Stampino
    Weidong Wendy Ma
    Arthur Kudla
    Geoffrey Chan
    Amer M. Zeidan
    Annals of Hematology, 2022, 101 : 1689 - 1701
  • [45] The Effects of Continued Azacitidine (AZA) Treatment Cycles on Response in Higher-Risk Patients (Pts) with Myelodysplastic Syndromes (MDS)
    Silverman, Lewis R.
    Fenaux, Pierre
    Mufti, Ghulam J.
    Santini, Valeria
    Hellstrom-Lindberg, Eva
    Gattermann, Norbert
    Sanz, Guillermo
    List, Alan F.
    Gore, Steven D.
    Seymour, John F.
    Backstrom, Jay
    McKenzie, David
    Beach, C. L.
    BLOOD, 2008, 112 (11) : 91 - 91
  • [46] Detection of TP53 Mutations in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML). a Comparison Between a Functional Method (FASAY) and Next Generation Sequencing (NGS)
    Bally, Cecile
    Renneville, Aline
    Ades, Lionel
    Preudhomme, Claude
    de The, Hugues
    Fenaux, Pierre
    Lehmann-Che, Jacqueline
    BLOOD, 2014, 124 (21)
  • [47] TP53 MUTATIONS IN HIGH RISK MYELODYSPLASTIC SYNDROMES PATIENTS TREATED WITH AZACITIDINE ACCORDING TO CETLAM GROUP PROTOCOL
    Cabezon, M.
    Bargay, J.
    Xicoy, B.
    Garcia, O.
    Tormo, M.
    Palomo, L.
    Marce, S.
    Valcarcel, D.
    Pedro, C.
    Jimenez, M. J.
    Borras, J.
    Guardia, R.
    Brunet, S.
    Marti, J. M.
    Garcia, A.
    Zamora, L.
    LEUKEMIA RESEARCH, 2017, 55 : S155 - S155
  • [48] TP53 mutations in older adults with acute myeloid leukemia
    Masamitsu Yanada
    Yukiya Yamamoto
    Sachiko Iba
    Akinao Okamoto
    Yoko Inaguma
    Masutaka Tokuda
    Satoko Morishima
    Tadaharu Kanie
    Shuichi Mizuta
    Yoshiki Akatsuka
    Masataka Okamoto
    Nobuhiko Emi
    International Journal of Hematology, 2016, 103 : 429 - 435
  • [49] Functional Classification of TP53 Mutations in Acute Myeloid Leukemia
    Dutta, Sayantanee
    Pregartner, Gudrun
    Ruecker, Frank G.
    Heitzer, Ellen
    Zebisch, Armin
    Bullinger, Lars
    Berghold, Andrea
    Doehner, Konstanze
    Sill, Heinz
    BLOOD, 2019, 134
  • [50] Molecular, Epigenetic, and Immune Landscape of TP53-mutated (TP53-M) Acute Myeloid Leukemia (AML) and Higher Risk Myelodysplastic Syndromes (HR-MDS)
    Bewersdorf, Jan Philipp
    Hasle, Vanessa
    Shallis, Rory Michael
    Thompson, Ethan G.
    de Menezes, Daniel Lopes
    Rose, Shelonitda
    Boss, Isaac W.
    Halene, Stephanie
    Haferlach, Torsten
    Fox, Brian
    Zeidan, Amer M.
    BLOOD, 2022, 140 : 6247 - 6249
12345